META
Meta Platforms, Inc.
META has the edge over VIV overall, supported by stronger valuation and stronger modeled upside.
VIV
Telefônica Brasil S.A.
VIV offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
VIV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
VIV's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
VIV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $9.23 | -22% |
| Fair | 16x | $12.05 | +1.3% |
| Current | 16x | $11.90 | — |
| Expensive | 18x | $13.36 | +12% |
Historical ranges are pointers, not guarantees.
VIV has the edge over META in the historical PE scenario, which offers more potential upside but is not a forecast.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
VIV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect VIV's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
VIV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.74 | +16% |
| Q1 2026 | $0.71 | +15% |
| Q4 2025 | $0.69 | +13% |
| Q3 2025 | $0.67 | +14% |
| Q2 2025 | $0.64 | +14% |
| Q1 2025 | $0.62 | +13% |
| Q4 2024 | $0.61 | +13% |
| Q3 2024 | $0.59 | +20% |
VIV's earnings per share have climbed steadily: $0.74 over the past year, up 16% from the year before, and higher year over year for 11 quarters in a row.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over VIV on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over VIV on profitability, with a higher operating margin.
VIV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.8B | +7.6% |
| Q1 2026 | $2.7B | +5.4% |
| Q4 2025 | $2.8B | +8.7% |
| Q3 2025 | $2.7B | +6.5% |
| Q2 2025 | $2.6B | +7.1% |
| Q1 2025 | $2.6B | +6.2% |
| Q4 2024 | $2.6B | +7.7% |
| Q3 2024 | $2.5B | +7.1% |
VIV's revenue has grown year over year for 22 quarters in a row: $2.8B last quarter, up 7.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | +1.2 points |
| Q1 2026 | 15% | +1 points |
| Q4 2025 | 16% | -1.1 points |
| Q3 2025 | 19% | +2.2 points |
| Q2 2025 | 15% | +0.4 points |
| Q1 2025 | 14% | -0.3 points |
| Q4 2024 | 17% | 0 points |
| Q3 2024 | 16% | +0.2 points |
VIV's operating margin was 16% last quarter, up 1.2 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
VIV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $538M | -17% |
| Q1 2026 | $516.5M | +8.1% |
| Q4 2025 | $484.8M | +45% |
| Q3 2025 | $403.4M | -0.4% |
| Q2 2025 | $649.8M | +3.6% |
| Q1 2025 | $477.9M | -8.6% |
| Q4 2024 | $334.1M | +59% |
| Q3 2024 | $404.9M | -5.7% |
VIV has the edge over META on cash flow, with more consistent year-over-year improvement.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over VIV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
VIV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +7.3M shares |
| 1 year | +0.3% | +5.1M shares |
| 3 years | -3.3% | -55.3M shares |
| 5 years | -4.7% | -79M shares |
| Available history | -5% | -83.6M shares |
VIV has 1.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $72,869 |
| Q1 2026 | $50,131 |
| Q4 2025 | $61.6M |
| Q3 2025 | $648.4M |
| Q2 2025 | $85.1M |
| Q1 2025 | $58.5M |
| Q4 2024 | $58.4M |
| Q3 2024 | $389.9M |
VIV spent $710M buying back its own shares over the past year, up 20% from the year before.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
VIV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.7x | Very low |
| Q3 2024 | 0.6x | Very low |
VIV has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
VIV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 32.0 | Neutral |
VIV's weekly RSI is 45 (neutral) and its Stochastic is 32 (neutral).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
VIV PE vs Communication Services Sector
| Metric | VIV | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | 2.4% below |
| PE % | 46 | 26 | 20 pts above |
VIV has the edge over META on valuation relative to its sector.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
VIV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 0.3% below |
| 20 week MA | $12.3 | 2.9% below |
| 50 week MA | $13.5 | 12% below |
| 100 week MA | $12.0 | 0.5% below |
| 200 week MA | $10.5 | 13% above |
VIV has fallen below most of its moving averages, though it's still 13% above its 200-week average.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.
VIV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.4 | $8.71 | -39% |
| 2021 | $8.71 | $8.76 | +0.6% |
| 2022 | $8.76 | $7.42 | -15% |
| 2023 | $7.42 | $10.9 | +47% |
| 2024 | $10.9 | $7.63 | -30% |
| 2025 | $7.63 | $11.9 | +56% |
| 2026 YTD | $11.9 | $11.9 | +0.1% |
VIV has the edge over META on returns for 2026, with the stronger performance.